Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$40 | -$39 | -$33 | -$34 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $1 | $1 | $1 | $1 |
| Stock-Based Comp. | $11 | $12 | $7 | $4 |
| Change in WC | $0 | -$2 | -$4 | $0 |
| Other Non-Cash | $1 | $0 | $0 | $0 |
| Operating Cash Flow | -$27 | -$28 | -$29 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$6 | -$5 | $0 | $0 |
| Investing Cash Flow | -$6 | -$5 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $14 | $14 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $33 | -$4 | $0 | $0 |
| Financing Cash Flow | $33 | $10 | $14 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$23 | -$15 | -$28 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3 | $26 | $42 | $70 |
| End Cash | $4 | $3 | $26 | $42 |
| Free Cash Flow | -$27 | -$28 | -$29 | -$28 |